B of A Securities Initiates Coverage On Amphastar Pharma With Neutral Rating, Announces Price Target of $63
B of A Securities Initiates Coverage On Amphastar Pharma With Neutral Rating, Announces Price Target of $63
Bof A Securities以中性評級啓動對Amphastar Pharma的報道，宣佈目標股價爲63美元
B of A Securities analyst Jason Gerberry initiates coverage on Amphastar Pharma (NASDAQ:AMPH) with a Neutral rating and announces Price Target of $63.
Bof A Securities分析師傑森·格伯裏以中性評級開始對Amphastar Pharma（納斯達克股票代碼：AMPH）進行報道，並宣佈目標股價爲63美元。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。